Bio-Rad Laboratories Net Profit Margin 2006-2019 | BIO

Current and historical net profit margin for Bio-Rad Laboratories (BIO) from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Bio-Rad Laboratories net profit margin for the three months ending September 30, 2019 was .
Bio-Rad Laboratories Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-09-30 $2.31B $0.38B 16.31%
2019-06-30 $2.29B $0.90B 39.49%
2019-03-31 $2.29B $0.57B 25.00%
2018-12-31 $2.29B $0.37B 15.94%
2018-09-30 $2.29B $1.28B 55.67%
2018-06-30 $2.28B $1.03B 45.12%
2018-03-31 $2.21B $0.77B 34.67%
2017-12-31 $2.16B $0.12B 5.65%
2017-09-30 $2.11B $0.02B 0.76%
2017-06-30 $2.09B $0.01B 0.58%
2017-03-31 $2.10B $0.03B 1.19%
2016-12-31 $2.07B $0.03B 1.21%
2016-09-30 $2.07B $0.09B 4.55%
2016-06-30 $2.03B $0.09B 4.58%
2016-03-31 $2.02B $0.10B 5.10%
2015-12-31 $2.02B $0.11B 5.40%
2015-09-30 $2.05B $0.10B 4.98%
2015-06-30 $2.11B $0.10B 4.60%
2015-03-31 $2.14B $0.10B 4.72%
2014-12-31 $2.18B $0.09B 4.14%
2014-09-30 $2.18B $0.08B 3.72%
2014-06-30 $2.15B $0.06B 2.88%
2014-03-31 $2.14B $0.07B 3.03%
2013-12-31 $2.13B $0.08B 3.66%
2013-09-30 $2.10B $0.09B 4.33%
2013-06-30 $2.10B $0.14B 6.72%
2013-03-31 $2.08B $0.15B 7.39%
2012-12-31 $2.07B $0.17B 7.97%
2012-09-30 $2.05B $0.18B 8.90%
2012-06-30 $2.06B $0.19B 8.97%
2012-03-31 $2.08B $0.18B 8.53%
2011-12-31 $2.07B $0.18B 8.63%
2011-09-30 $2.06B $0.19B 9.09%
2011-06-30 $2.01B $0.19B 9.24%
2011-03-31 $1.96B $0.18B 9.39%
2010-12-31 $1.93B $0.19B 9.65%
2010-09-30 $1.89B $0.16B 8.26%
2010-06-30 $1.88B $0.15B 7.99%
2010-03-31 $1.84B $0.15B 8.17%
2009-12-31 $1.78B $0.15B 8.13%
2009-09-30 $1.74B $0.10B 5.70%
2009-06-30 $1.72B $0.09B 5.12%
2009-03-31 $1.74B $0.09B 5.34%
2008-12-31 $1.76B $0.09B 5.05%
2008-09-30 $1.78B $0.11B 6.14%
2008-06-30 $1.67B $0.11B 6.51%
2008-03-31 $1.56B $0.09B 5.89%
2007-12-31 $1.46B $0.09B 6.36%
2007-09-30 $1.35B $0.10B 7.29%
2007-06-30 $1.31B $0.09B 7.10%
2007-03-31 $1.29B $0.10B 7.68%
2006-12-31 $1.27B $0.10B 8.08%
2006-09-30 $1.24B $0.10B 8.00%
2006-06-30 $1.22B $0.09B 7.57%
2006-03-31 $1.19B $0.08B 6.56%
2005-12-31 $1.18B $0.08B 6.78%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $10.615B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.706B 27.85
Medtronic (MDT) Ireland $152.160B 21.02
Stryker (SYK) United States $75.917B 25.53
Boston Scientific (BSX) United States $62.848B 29.66
Baxter (BAX) United States $42.866B 25.99
Essilor Luxottica (ESLOY) France $34.245B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.456B 19.11
Terumo (TRUMY) Japan $27.092B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.394B 0.00
Coloplast (CLPBY) Denmark $24.797B 38.27
ResMed (RMD) United States $22.090B 40.75
Smith & Nephew SNATS (SNN) United Kingdom $20.228B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Insulet (PODD) United States $10.859B 516.62
William Demant Holdings (WILYY) Denmark $7.675B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.340B 13.69
Hill-Rom Holdings (HRC) United States $7.289B 21.49
Canopy Growth (CGC) Canada $7.208B 0.00
Haemonetics (HAE) United States $5.904B 39.89
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.947B 31.08
ICU Medical (ICUI) United States $3.686B 24.03
Neogen (NEOG) United States $3.583B 59.96
GW Pharmaceuticals (GWPH) United Kingdom $3.293B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.073B 0.00
Quidel (QDEL) United States $2.950B 27.99
Aurora Cannabis (ACB) Canada $2.865B 0.00
Agios Pharmaceuticals (AGIO) United States $2.750B 0.00
National Vision Holdings (EYE) United States $2.495B 56.30
Cardiovascular Systems (CSII) United States $1.607B 0.00
Aphria (APHA) $1.384B 0.00
InMode (INMD) Israel $1.242B 0.00
AtriCure (ATRC) United States $1.206B 0.00
VAREX IMAGING (VREX) United States $1.199B 24.01
TG Therapeutics (TGTX) United States $1.006B 0.00
Phibro Animal Health (PAHC) United States $0.969B 18.14
NanoString Technologies (NSTG) United States $0.912B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.820B 31.41
Lantheus Holdings (LNTH) United States $0.795B 19.86
LeMaitre Vascular (LMAT) United States $0.711B 39.98
PetIQ (PETQ) United States $0.695B 16.96
Quanterix (QTRX) United States $0.676B 0.00
Omeros (OMER) United States $0.667B 0.00
HEXO (HEXO) $0.576B 0.00
Cerus (CERS) United States $0.560B 0.00
Surmodics (SRDX) United States $0.552B 57.38
MacroGenics (MGNX) United States $0.518B 0.00
OraSure Technologies (OSUR) United States $0.497B 29.80
Meridian Bioscience (VIVO) United States $0.413B 14.21
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.68
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.320B 130.58
Zynex (ZYXI) United States $0.305B 34.48
Bovie Medical (APYX) United States $0.276B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.274B 0.00
United Health Products (UEEC) United States $0.251B 0.00
Vapotherm (VAPO) United States $0.244B 0.00
Viemed Healthcare (VMD) United States $0.238B 25.08
Repro-Med Systems (KRMD) United States $0.228B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Female Health (VERU) United States $0.157B 0.00
Rockwell Medical (RMTI) United States $0.142B 0.00
Cytosorbents (CTSO) United States $0.136B 0.00
Fonar (FONR) United States $0.130B 9.18
MTech Acquisition (KERN) United States $0.128B 0.00
Chimerix (CMRX) United States $0.110B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 22.93
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00